The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation.
about
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The Novel Antitubulin Agent TR ...... and Inhibits HIF-1α Activation
@nl
The Novel Antitubulin Agent TR ...... nd Inhibits HIF-1α Activation.
@ast
The Novel Antitubulin Agent TR ...... nd Inhibits HIF-1α Activation.
@en
type
label
The Novel Antitubulin Agent TR ...... and Inhibits HIF-1α Activation
@nl
The Novel Antitubulin Agent TR ...... nd Inhibits HIF-1α Activation.
@ast
The Novel Antitubulin Agent TR ...... nd Inhibits HIF-1α Activation.
@en
prefLabel
The Novel Antitubulin Agent TR ...... and Inhibits HIF-1α Activation
@nl
The Novel Antitubulin Agent TR ...... nd Inhibits HIF-1α Activation.
@ast
The Novel Antitubulin Agent TR ...... nd Inhibits HIF-1α Activation.
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
The Novel Antitubulin Agent TR ...... and Inhibits HIF-1α Activation
@en
P2093
Giuseppe Basso
Paola Oliva
Roberta Bortolozzi
Romeo Romagnoli
Stefania Mitola
P2860
P2888
P3181
P356
10.1038/SREP27886
P407
P577
2016-06-13T00:00:00Z
P6179
1048444084